A review published in Experimental Gerontology examines the potential of mesenchymal stem cells (MSCs) and their secreted exosomes (Exos) to impact the biological hallmarks of aging. Rather than treating aging as a single-track process, the article frames it as a complex interaction of interrelated features such as genomic instability, mitochondrial dysfunction, and cellular senescence.
MSCs, known for their regenerative and differentiation capabilities, exert much of their effect through homing to damaged tissue, paracrine signaling, and direct cellular differentiation. Exosomes—extracellular vesicles secreted by MSCs—are highlighted as key mediators in this signaling process, capable of carrying functional proteins, RNA, and other molecules to target cells.
The review identifies several hallmarks of aging that can potentially be modulated by MSCs or MSC-derived exosomes, including:
- Telomere attrition and genomic instability
- Loss of proteostasis
- Impaired autophagy
- Mitochondrial dysfunction
- Chronic inflammation and altered intercellular communication
The authors note that existing research suggests MSC-derived exosomes may play a role in delaying the progression of aging-related diseases by improving indicators linked to these hallmarks.
It presents these therapies as immediate solutions and the paper highlights their potential as part of a broader, evolving strategy for age-related intervention.
